Biotie Therapies Corp.: Neurelis, Biote partner on product expansion

San Diego-based specialty pharmaceutical company, Neurelis, and Finnish specialised drug development firm, Biotie Therapies, have entered into an agreement to further develop the former's NRL-1 (intranasal diazepam) and to provide the latter with the exclusive option to acquire all its outstanding shares of its merger target. Under the terms of the option and merger agreement [...]